Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer.

about

Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond

P2860

Q56891609-D824E855-AAD5-4289-9748-8A6DB48F16F9

P2860

Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer.

Item

http://www.wikidata.org/entity/Q55343888

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Transcriptome-derived stromal ...... comes of patients with cancer.

@en

Transcriptome-derived stromal ...... comes of patients with cancer.

@nl

type

Item

label

Transcriptome-derived stromal ...... comes of patients with cancer.

@en

Transcriptome-derived stromal ...... comes of patients with cancer.

@nl

prefLabel

Transcriptome-derived stromal ...... comes of patients with cancer.

@en

Transcriptome-derived stromal ...... comes of patients with cancer.

@nl

P1476

Transcriptome-derived stromal ...... comes of patients with cancer.

@en

P2093

Chao-Qun Xu

http://www.w3.org/2001/XMLSchema#string

Hua Ye

http://www.w3.org/2001/XMLSchema#string

Hua-Qin He

http://www.w3.org/2001/XMLSchema#string

Huan Tao

http://www.w3.org/2001/XMLSchema#string

Li-Chun Xue

http://www.w3.org/2001/XMLSchema#string

Ling Li

http://www.w3.org/2001/XMLSchema#string

Shi-Wei Ma

http://www.w3.org/2001/XMLSchema#string

Tian Tian

http://www.w3.org/2001/XMLSchema#string

Ying-Fu Liu

http://www.w3.org/2001/XMLSchema#string

Yue-Xian Zhong

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Tumour evolution inferred by single-cell sequencing

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

Proteomics. Tissue-based map of the human proteome

Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?

Inferring tumour purity and stromal and immune cell admixture from expression data

An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples

Stromal gene expression predicts clinical outcome in breast cancer.

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.

P304

4351-4357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.7855

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wei Liu

P577

2018-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29541203

http://www.w3.org/2001/XMLSchema#string

P921

transcriptome

P932

5835954

http://www.w3.org/2001/XMLSchema#string

Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer.

about

P2860

P2860

Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932